Eliquis vs. Savaysa for Atrial Fibrillation and Stroke Risk Reduction: Important Differences and Potential Risks.

Eliquis

(apixaban)

Savaysa

(edoxaban)

Summary for Eliquis

Prescription only

Eliquis (apixaban) is an anticoagulant (blood thinner) used to prevent and treat blood clots. It can lower the risk of serious conditions like stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE). The medication comes as a tablet or liquid and is taken by mouth twice a day. Common side effects include bleeding and bruising. Although generic versions have been approved by the FDA, they might not be available until 2026.

Indications for Eliquis

Adults:

Lower the risk of stroke or blood clots in people with atrial fibrillation (AFib) not caused by a heart valve problem
Treat blood clots in the legs (deep vein thrombosis (DVT)) or lungs (pulmonary embolism (PE))
Prevent DVT and PE after knee or hip replacement surgery
Lower the risk of DVT or PE coming back after treatment

Children:

Treat blood clots and lower the risk of new clots in children from birth and older

Pros and Cons for Eliquis

Pros

No regular blood monitoring required
Can be taken with or without food
Approved for both children and adults

Cons

Need to take it twice a day
Most common side effect is bleeding
Not easily reversible in life-threatening bleeds

Common Side Effects for Eliquis

Adults:

Any bleeding (up to 15%)

Children:

Any bleeding (up to 36%)
Headache (16%)
Vomiting (14%)

Warnings for Eliquis

Higher risk of blood clots if stopped too early
Paralysis in the spine
Bleeding
Not recommended in people with prosthetic heart valves
Not recommended in people with antiphospholipid syndrome

Summary for Savaysa

Prescription only

Savaysa, the brand name for edoxaban, is an anticoagulant (blood thinner). It’s used to help prevent blood clots and strokes in certain people with atrial fibrillation. This medication can also treat blood clots. The dose is typically one 60 mg tablet by mouth once daily, but it might be lower if you have kidney problems. Since it’s a blood thinner medication, Savaysa (edoxaban) can raise your chance of bleeding as a side effect. As of early 2025, there's no FDA-approved generic version available yet.

Indications for Savaysa

Prevention of stroke and blood clots in people with nonvalvular atrial fibrillation (NVAF)
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) after 5 to 10 days of therapy with an injectable blood thinner

Pros and Cons for Savaysa

Pros

Oral medication that's only taken once a day
Can take with or without food and doesn't interact with any specific foods
Doesn't require frequent blood tests to check how well it’s working and how safe it is

Cons

Not for people with nonvalvular atrial fibrillation (NVAF) whose kidneys work too well
Not recommended if you have artificial heart valves or certain problems with your heart valves
Doesn't have an antidote (an option to reverse serious bleeding)

Common Side Effects for Savaysa

Any type of bleeding

Warnings for Savaysa

Less effective for people with atrial fibrillation whose kidneys work too well
Higher risk of blood clots or stroke when you stop the medication too soon
Bleeding risk
Risk of bleeding around the spinal cord after spinal procedures
Higher risk of clotting in people with triple-positive antiphospholipid syndrome